Penicillin conversion

Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see ) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Demain, Arnold L, Cho, Hiroshi, Piret, Jacqueline M, Adrio, Josè L, Fernandez, Maria-Josefa E, Bàez-Vàsquez, Marco A, Hintermann, Gilberto
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Demain, Arnold L
Cho, Hiroshi
Piret, Jacqueline M
Adrio, Josè L
Fernandez, Maria-Josefa E
Bàez-Vàsquez, Marco A
Hintermann, Gilberto
description Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see ) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG. ). The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_06383773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>06383773</sourcerecordid><originalsourceid>FETCH-uspatents_grants_063837733</originalsourceid><addsrcrecordid>eNrjZBANSM3LTM7MycnMU0jOzytLLSrOzM_jYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDM2MLY3NzYmAglAH0JImE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Penicillin conversion</title><source>USPTO Issued Patents</source><creator>Demain, Arnold L ; Cho, Hiroshi ; Piret, Jacqueline M ; Adrio, Josè L ; Fernandez, Maria-Josefa E ; Bàez-Vàsquez, Marco A ; Hintermann, Gilberto</creator><creatorcontrib>Demain, Arnold L ; Cho, Hiroshi ; Piret, Jacqueline M ; Adrio, Josè L ; Fernandez, Maria-Josefa E ; Bàez-Vàsquez, Marco A ; Hintermann, Gilberto ; Massachusetts Institute of Technology</creatorcontrib><description>Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see ) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG. ). The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.</description><language>eng</language><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6383773$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6383773$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Demain, Arnold L</creatorcontrib><creatorcontrib>Cho, Hiroshi</creatorcontrib><creatorcontrib>Piret, Jacqueline M</creatorcontrib><creatorcontrib>Adrio, Josè L</creatorcontrib><creatorcontrib>Fernandez, Maria-Josefa E</creatorcontrib><creatorcontrib>Bàez-Vàsquez, Marco A</creatorcontrib><creatorcontrib>Hintermann, Gilberto</creatorcontrib><creatorcontrib>Massachusetts Institute of Technology</creatorcontrib><title>Penicillin conversion</title><description>Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see ) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG. ). The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZBANSM3LTM7MycnMU0jOzytLLSrOzM_jYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgysDM2MLY3NzYmAglAH0JImE</recordid><startdate>20020507</startdate><enddate>20020507</enddate><creator>Demain, Arnold L</creator><creator>Cho, Hiroshi</creator><creator>Piret, Jacqueline M</creator><creator>Adrio, Josè L</creator><creator>Fernandez, Maria-Josefa E</creator><creator>Bàez-Vàsquez, Marco A</creator><creator>Hintermann, Gilberto</creator><scope>EFH</scope></search><sort><creationdate>20020507</creationdate><title>Penicillin conversion</title><author>Demain, Arnold L ; Cho, Hiroshi ; Piret, Jacqueline M ; Adrio, Josè L ; Fernandez, Maria-Josefa E ; Bàez-Vàsquez, Marco A ; Hintermann, Gilberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_063837733</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Demain, Arnold L</creatorcontrib><creatorcontrib>Cho, Hiroshi</creatorcontrib><creatorcontrib>Piret, Jacqueline M</creatorcontrib><creatorcontrib>Adrio, Josè L</creatorcontrib><creatorcontrib>Fernandez, Maria-Josefa E</creatorcontrib><creatorcontrib>Bàez-Vàsquez, Marco A</creatorcontrib><creatorcontrib>Hintermann, Gilberto</creatorcontrib><creatorcontrib>Massachusetts Institute of Technology</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Demain, Arnold L</au><au>Cho, Hiroshi</au><au>Piret, Jacqueline M</au><au>Adrio, Josè L</au><au>Fernandez, Maria-Josefa E</au><au>Bàez-Vàsquez, Marco A</au><au>Hintermann, Gilberto</au><aucorp>Massachusetts Institute of Technology</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Penicillin conversion</title><date>2002-05-07</date><risdate>2002</risdate><abstract>Penicillin began the antibiotic revolution. Providing the first real weapon against microbial infections, penicillin (see ) first appeared to be a "magic bullet" that would cure all of man's ills. Infectious microbes soon developed resistance to penicillins, however. Great efforts in the pharmaceutical industry have focussed and still focus on the development of alternative antibiotics. One of the most useful families of agents is the cephalosporins (see FIG. ). The present invention provides a biological system for expanding the dethiazolidine ring of penicillins into the dehydrothiazine ring of cephalosporins or cephalosporin precursors. In particular, the invention defines reaction conditions under which expandase enzyme can convert penicillin substrates other than penicillin N into cephalosporins. The invention therefore provides a relatively inexpensive, uncomplicated, and environmentally friendly biological system for cephalosporin production from penicillins, which system can replace the synthetic chemical approaches currently utilized. In particular, the invention provides a system for producing DOAG and/or DAG, which can be enzymatically converted into 7-ADCA and 7-ADAC, which, in turn, can be enzymatically or chemically converted into valuable cephalosporins of commerce.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_06383773
source USPTO Issued Patents
title Penicillin conversion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A39%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Demain,%20Arnold%20L&rft.aucorp=Massachusetts%20Institute%20of%20Technology&rft.date=2002-05-07&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E06383773%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true